作用于RNA (ADAR) 酶的腺胺酶:从奇怪到神奇的旅程
Liam P Keegan1, Khadija Hajji1, Mary A O'Connell1
1CEITEC, Masaryk University, Kamenice 735/5, E35, Brno 62500, Czechia.
Accounts of chemical research
|October 31, 2023
概括
作用于RNA (ADAR) 酶的腺氨酸脱氨酶对于RNA编辑至关重要. ADAR1阻止自我RNA触发天生的免疫力,而ADAR2则在神经系统中产生蛋白质多样性.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
背景情况:
- 作用于RNA (ADAR) 的腺胺酶催化腺转化为双链RNA (dsRNA) 的 inosine转化.
- ADARs对于神经系统功能,造血和天生的免疫力至关重要.
- 编辑ADAR2产生蛋白质多样性,而编辑ADAR1的重复元素防止先天免疫激活.
研究的目的:
- 提供ADAR酶研究的历史视角.
- 探索ADAR蛋白质的表征,定位和翻译后修改.
- 讨论使用遗传模型来了解ADAR功能和人类突变的后果.
主要方法:
- 净化和克隆ADAR1和ADAR2的基因.
- 描述ADAR蛋白质的特性和功能.
- 利用小鼠和虫的遗传模型来研究ADARs.
主要成果:
- 在中枢神经系统 (CNS) 中,ADAR2对于蛋白质多样性至关重要.
- ADAR1编辑重复的元素,防止自我RNA通过Mda5.5激活先天免疫.
- ADAR1在天生的免疫力中的作用与其编辑dsRNA结构的能力有关.
结论:
- 阿达尔酶在生物过程中发挥着多样化,重要的作用.
- ADAR1充当"自我"RNA条形码,对天生的免疫至关重要.
- 人类ADAR基因的突变会产生严重的后果.
相关概念视频
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Ribozymes
12.3K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
12.3K
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K


